Lasa Supergenerics Limited (LASA.NS)
INR 17.37
(-2.74%)
INR 17.37
(-2.74%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 121.02 Million INR | -48.4% |
| 2022 | 234.53 Million INR | -48.01% |
| 2021 | 451.1 Million INR | -49.13% |
| 2020 | 886.86 Million INR | 23.62% |
| 2019 | 717.43 Million INR | 76.48% |
| 2018 | 406.51 Million INR | -41.15% |
| 2017 | 690.8 Million INR | 4.49% |
| 2016 | 661.09 Million INR | 0.0% |
| 2015 | - INR | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 43.56 Million INR | 2450.7% |
| 2023 Q4 | 1.7 Million INR | -93.16% |
| 2023 FY | 121.02 Million INR | -48.4% |
| 2023 Q1 | 102.5 Million INR | 2.84% |
| 2023 Q3 | 24.98 Million INR | -67.94% |
| 2023 Q2 | 77.93 Million INR | -23.98% |
| 2022 Q3 | 61.67 Million INR | -20.49% |
| 2022 Q1 | -4.38 Million INR | -102.66% |
| 2022 FY | 234.53 Million INR | -48.01% |
| 2022 Q4 | 99.67 Million INR | 61.62% |
| 2022 Q2 | 77.57 Million INR | 1868.58% |
| 2021 Q1 | 143.66 Million INR | -19.07% |
| 2021 FY | 451.1 Million INR | -49.13% |
| 2021 Q4 | 164.66 Million INR | 362.27% |
| 2021 Q3 | 35.62 Million INR | -66.76% |
| 2021 Q2 | 107.15 Million INR | -25.41% |
| 2020 Q3 | 250.23 Million INR | 3.9% |
| 2020 Q4 | 177.5 Million INR | -29.07% |
| 2020 FY | 886.86 Million INR | 23.62% |
| 2020 Q1 | 218.28 Million INR | -14.05% |
| 2020 Q2 | 240.84 Million INR | 10.34% |
| 2019 FY | 717.43 Million INR | 76.48% |
| 2019 Q4 | 253.94 Million INR | 44.96% |
| 2019 Q3 | 175.18 Million INR | 6.67% |
| 2019 Q2 | 164.23 Million INR | 32.38% |
| 2019 Q1 | 124.06 Million INR | 11.19% |
| 2018 Q3 | 69.94 Million INR | -34.91% |
| 2018 Q2 | 107.45 Million INR | -8.58% |
| 2018 Q1 | 117.54 Million INR | 45.3% |
| 2018 FY | 406.51 Million INR | -41.15% |
| 2018 Q4 | 111.57 Million INR | 59.52% |
| 2017 FY | 690.8 Million INR | 4.49% |
| 2017 Q1 | 220.44 Million INR | 0.0% |
| 2017 Q4 | 80.89 Million INR | -60.2% |
| 2017 Q2 | 218.2 Million INR | -1.02% |
| 2017 Q3 | 203.23 Million INR | -6.86% |
| 2016 Q1 | 158.95 Million INR | 0.0% |
| 2016 FY | 661.09 Million INR | 0.0% |
| 2015 FY | - INR | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Alembic Pharmaceuticals Limited | 26.78 Billion INR | 99.548% |
| Hester Biosciences Limited | 1.27 Billion INR | 90.497% |
| Aarti Drugs Limited | 8.31 Billion INR | 98.545% |
| Aarti Pharmalabs Limited | 5.83 Billion INR | 97.924% |
| Albert David Limited | 1.4 Billion INR | 91.405% |
| Alembic Limited | 1 Billion INR | 87.898% |
| Alkem Laboratories Limited | 52.29 Billion INR | 99.769% |
| Bafna Pharmaceuticals Limited | 452.15 Million INR | 73.233% |
| Bajaj HealthCare Limited | 1.47 Billion INR | 91.777% |
| Biofil Chemicals and Pharmaceuticals Limited | 12.54 Million INR | -864.767% |
| Brooks Laboratories Limited | 65.62 Million INR | -84.441% |
| Eris Lifesciences Limited | 10.42 Billion INR | 98.839% |
| FDC Limited | 6.58 Billion INR | 98.162% |
| Glenmark Life Sciences Limited | 12.43 Billion INR | 99.027% |
| Gufic Biosciences Limited | 4.07 Billion INR | 97.029% |
| Hikal Limited | 5.95 Billion INR | 97.969% |
| Ind-Swift Limited | 2.17 Billion INR | 94.429% |
| Innova Captab Limited | 3.46 Billion INR | 96.507% |
| IOL Chemicals and Pharmaceuticals Limited | 4.71 Billion INR | 97.435% |
| Jagsonpal Pharmaceuticals Limited | 652.59 Million INR | 81.454% |
| Jubilant Pharmova Limited | 19.64 Billion INR | 99.384% |
| Lincoln Pharmaceuticals Limited | 1.88 Billion INR | 93.586% |
| Lupin Limited | 125.09 Billion INR | 99.903% |
| Mangalam Drugs & Organics Limited | 691.19 Million INR | 82.49% |
| Medico Remedies Limited | 262.14 Million INR | 53.831% |
| Morepen Laboratories Limited | 6.16 Billion INR | 98.036% |
| Nectar Lifesciences Limited | 4.82 Billion INR | 97.491% |
| Orchid Pharma Limited | 2.32 Billion INR | 94.784% |
| Procter & Gamble Health Limited | 5.78 Billion INR | 97.907% |
| RPG Life Sciences Limited | 2.48 Billion INR | 95.126% |
| Kilitch Drugs (India) Limited | 620.47 Million INR | 80.494% |
| Sigachi Industries Limited | 2 Billion INR | 93.955% |
| Solara Active Pharma Sciences Limited | -1.65 Billion INR | 107.309% |
| Suven Pharmaceuticals Limited | 4.12 Billion INR | 97.065% |
| Themis Medicare Limited | 2.42 Billion INR | 94.999% |
| Unichem Laboratories Limited | 4.86 Billion INR | 97.512% |
| Vaishali Pharma Limited | 90.32 Million INR | -33.997% |
| Wanbury Limited | 1.73 Billion INR | 93.007% |
| Windlas Biotech Limited | 1.33 Billion INR | 90.96% |
| ZIM Laboratories Limited | 1.26 Billion INR | 90.454% |
| Ind-Swift Laboratories Limited | 4.13 Billion INR | 97.072% |
| Ipca Laboratories Limited | 48.58 Billion INR | 99.751% |
| Sun Pharmaceutical Industries Limited | 258.48 Billion INR | 99.953% |
| Venus Remedies Limited | 2.18 Billion INR | 94.455% |
| Sakar Healthcare Limited | 699.58 Million INR | 82.7% |
| Aurobindo Pharma Limited | 109.54 Billion INR | 99.89% |
| Divi's Laboratories Limited | 32.44 Billion INR | 99.627% |
| AstraZeneca Pharma India Limited | 6.22 Billion INR | 98.055% |
| Mankind Pharma Limited | 42.19 Billion INR | 99.713% |
| Sequent Scientific Limited | 2.97 Billion INR | 95.937% |
| Laurus Labs Limited | 15.44 Billion INR | 99.217% |
| Neuland Laboratories Limited | 8.24 Billion INR | 98.533% |
| J. B. Chemicals & Pharmaceuticals Limited | 15.25 Billion INR | 99.207% |
| Glenmark Pharmaceuticals Limited | 69.34 Billion INR | 99.825% |
| Zydus Lifesciences Limited | 125.21 Billion INR | 99.903% |
| Amrutanjan Health Care Limited | 2.09 Billion INR | 94.22% |
| Wockhardt Limited | 7.72 Billion INR | 98.432% |
| Bal Pharma Limited | 770.19 Million INR | 84.286% |
| Dr. Reddy's Laboratories Limited | 163.6 Billion INR | 99.926% |
| Bliss GVS Pharma Limited | 3.69 Billion INR | 96.725% |
| Par Drugs and Chemicals Limited | 529.13 Million INR | 77.127% |
| Caplin Point Laboratories Limited | 9.2 Billion INR | 98.685% |
| Shilpa Medicare Limited | 3.56 Billion INR | 96.602% |
| Valiant Laboratories Limited | 138.02 Million INR | 12.316% |
| Ajanta Pharma Limited | 21.06 Billion INR | 99.425% |
| Aarey Drugs & Pharmaceuticals Limited | 113.02 Million INR | -7.079% |
| Granules India Limited | 16.79 Billion INR | 99.28% |
| Medicamen Biotech Limited | 495.49 Million INR | 75.574% |
| Syncom Formulations (India) Limited | 559.5 Million INR | 78.368% |
| Piramal Enterprises Limited | 8.04 Billion INR | 98.495% |
| Torrent Pharmaceuticals Limited | 46.75 Billion INR | 99.741% |
| NATCO Pharma Limited | 25.73 Billion INR | 99.53% |
| Suven Life Sciences Limited | -200.79 Million INR | 160.275% |
| Krebs Biochemicals & Industries Limited | -108.74 Million INR | 211.295% |
| Strides Pharma Science Limited | 14.38 Billion INR | 99.159% |
| Indoco Remedies Limited | 8.04 Billion INR | 98.495% |
| Alpa Laboratories Limited | 188.89 Million INR | 35.927% |
| Sun Pharma Advanced Research Company Limited | 391.06 Million INR | 69.051% |